logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.

    Article - En anglais

    Objectives

    A number of studies have been focused on the mortality of parkinsonian patients. as compared with the rest of the population.

    In these studies, a mortality greater than expected on the basis of mortality of the general population has been shown.

    Nevertheless, just a few of these studies have investigated in detail the specific causes of death, probably as a consequence of both small cohort sizes and a short time period of observation.

    The aim of this study was to estimate cause-specific mortality in a cohort of patients treated with antiparkinsonian drugs.

    Methods

    The study was performed on a wide population-based cohort of patients identified and followed-up through the computerized health databases of the Italian province of Rome (about 3.800.000 inhabitants).

    The follow-up lasted from January 1987 to December 1994.

    Standardized Mortality Ratios (SMR) were calculated for each specific cause of death, using the Rome province population as reference.

    Results

    A cohort of 10,322 subjects. receiving antiparkinsonian drugs, were identified.

    There were 4328 deaths on an average follow-up of 5.7 years.

    This figure was 17% higher than was expected.

    A gradual decrease in SMR was observed in the oldest age groups.

    Statistically significant (95%) excesses of death were related to the nervous system (SMR=1037 ; 95% CI 964-1110, mental disorders (SMR=182 ; 95% CI 129-246), and endocrine and metabolic diseases (SMR=117 ; 95% Cl 102-133). (...)

    Mots-clés Pascal : Mortalité, Etude cohorte, Antiparkinsonien, Chimiothérapie, Italie, Europe, Epidémiologie, Etiologie, Traitement, Homme

    Mots-clés Pascal anglais : Mortality, Cohort study, Antiparkinson agent, Chemotherapy, Italy, Europe, Epidemiology, Etiology, Treatment, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0094874

    Code Inist : 002B02B06. Création : 14/05/1998.